Metraipolis › archive › dc_c61a37726c50

Efficacy of ketogenic metabolic therapy as an adjuvant to the current standard of care in the treatment of glioblastoma: A systematic review of clinical trials — Europe PMC PMID:41379280

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41379280
DOI: 10.1007/s12032-[numero omesso]-7
License (as archived): solo-consultazione
Archived: 2026-11-07T17:49:25.324Z
SHA-256 of the archived text: 69e0340cc5b8e5a31bbc35d0095bb0918b726cdf05388fb943bd5eb957d90734
Stable URL of this page: https://metraipolis.com/documento/dc_c61a37726c50

How to cite

Efficacy of ketogenic metabolic therapy as an adjuvant to the current standard of care in the treatment of glioblastoma: A systematic review of clinical trials — Europe PMC PMID:41379280 — Europe PMC (en), https://europepmc.org/article/MED/41379280 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c61a37726c50 (Metraipolis archive dc_c61a37726c50, sha256 69e0340cc5b8e5a31bbc35d0095bb0918b726cdf05388fb943bd5eb957d90734)

BibTeX

@misc{dcc61a37726c50,
  title = {Efficacy of ketogenic metabolic therapy as an adjuvant to the current standard of care in the treatment of glioblastoma: A systematic review of clinical trials — Europe PMC PMID:41379280},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41379280},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c61a37726c50; sha256 69e0340cc5b8e5a31bbc35d0095bb0918b726cdf05388fb943bd5eb957d90734},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41379280. Agents can read the archived copy with the MCP tool read_document.